RadNet, Inc. Profile Avatar - Palmy Investing

RadNet, Inc.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultraso…
Medical - Diagnostics & Research
US, Los Angeles [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 50% Balanced
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA 62.24 73.61 45.37
Graham Fair Price 40.90 3.37 2.39
PEG 125.42 -6.47 2.87
Price/Book 2.03 3.82 3.74
Price/Cash Flow 71.11 -82.69 48.33
Prices/Earnings 5.48 -299.96 -317.35
Price/Sales 37.52 7.72 5.62
Price/FCF 71.11 -82.69 48.33
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -63.22 0.03 0.07
Operating Margin -63.22 0.03 0.07
ROA -45.24 < 0.005 < 0.005
ROE < 0.005 < 0.005 -7.95
ROIC 0.02 0.01 -44.45
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.02 -0.03 -22.69
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.28 -0.62 -121.58
EPS QOQ -1.11 -0.46 58.07
FCF QOQ 5.93 -1.83 -69.23
Revenue QOQ 0.05 0.03 -41.20
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) < 0.005 < 0.005 -7.31
Days Sales Outstanding (DSO) 40.47 46.67 15.30
Inventory Turnover 389278000.00 419957000.00 7.88
Debt/Capitalization 0.58 0.51 -13.45
Quick Ratio 1.22 1.75 44.39
Naive Interpretation member
04 - Leverage & Liquidity · Balanced
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 9.29 12.60 35.61
Cash 5.04 7.60 50.72
Capex -0.59 -0.83 -40.40
Free Cash Flow 0.72 -0.58 -19.13
Revenue 6.19 6.23 0.62
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.32 1.86 40.45
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 14.85 16.93 14.04
Naive Interpretation Member
06 - Financial Health · Weak
End of RDNT's Analysis
CIK: 790526 CUSIP: 750491102 ISIN: US7504911022 LEI: - UEI: -
Secondary Listings
RDNT has no secondary listings inside our databases.